Daniel Wong Email & Phone Number

San Francisco, Ca, Us

North Chicago, Illinois, Us

Oncology Early Development (OED) — Clinical trial acceleration, R&D strategy, capability building, data analytics

Boston, Ma, Us

Boston, Ma, Us

Management Consulting | Healthcare & Life SciencesSelect past engagements:- Drug infusion device partnership strategy for medical device company- mRNA vaccines and therapeutics manufacturing demand forecasting for CDMO- Wearable medical device prioritization assessment for large pharma- Market opportunity assessment of single-cell multi-omics (genomics, transcriptomics, proteomics) for LS tools company- Clinical market evaluation of spatial proteomics for LS tools company- T1D patient journey mapping for large pharma- Cell therapy product launch planning for large pharma- Retail channel strategy & market sizing of retail point-of-care diagnostics for large healthcare distributor- Portfolio prioritization & strategy for mid-size pharma in hematology- Research and clinical Dx market opportunity assessment of next-generation cancer cell models for LS tools company- Revenue forecasting of Parkinson's disease therapy for small-cap pharma

Vancouver, Bc, Ca

Field Sales | Cell Culture Systems & Solutions

San Francisco, Ca, Us

Supervised strategic consulting teams in market landscaping and indication prioritization engagements with large biopharma and clinical-stage biotech - Performed a structured assessment of ~35 viral disease drug development opportunities based on commercial opportunity, global health need, and scientific feasibility - Conducted a landscape assessment of anti-aging therapeutics to guide entry into the anti-aging market- Completed a tumor indication prioritization for clinical-stage oncology company developing a novel small molecule dual antagonist

San Francisco, Ca, Us

Assembled and led a 6-member strategic consulting team to conduct market landscape analysis on and technical diligence of microbiome-based therapeutics, diagnostics, and technologies for a multibillion-dollar biopharma company in the Bay Area

San Francisco, Ca, Us

• Performed due diligence (clinical target evaluation, disease indication prioritization, market opportunity analysis, and competitive landscaping) for an early-stage biotechnology company • Conducted interviews with key opinion leaders to identify current standards of care for six key disease indications, clinical unmet needs, and market pain and entry points for microbiome-based therapeutics

San Francisco, California, Us

Ph.D. Thesis: Mapping cellular diversity and lineage dynamics in the developing murine and human pancreasTechnical expertise: stem cell-based therapeutics, human embryonic stem cell culture and differentiation, CRISPR/Cas9-mediated genomic engineering, cell line development, flow cytometry, mouse husbandry and genetics, ISH/IHC, multi-spectral imaging, and single-cell RNA-seq analysis (R programming)

Newark, Ca, Us

• Pitched commercial presentations to clients in order to market ACD’s RNA in situ hybridization platform (RNAscope)• Served as a technical applications specialist and advised clients and current RNAscope users on experimental design, tissue preparation, RNAscope assay execution, and imaging parameters• Identified and met with academic scientists and university core directors to close sales deals and establish working relationships with ACD

Los Angeles, Ca, Us

Los Angeles, Ca, Us

Fellowships: Howard Hughes Undergraduate Research Scholar and Amgen Research Scholar

Doctor Of Philosophy (Ph.D.), Biomedical Sciences

Bachelor Of Science (B.S.), Molecular, Cell, And Developmental Biology

Education record